Medical Representatives in Ethiopia: What a Field Force Does for a Foreign Manufacturer
What medical representatives in Ethiopia do for a manufacturer, the rules on promoting medicines, the WHO baseline, and how to judge a partner's field force.
A manufacturer entering Ethiopia needs medical representatives on the ground, because a registered product does not sell itself to the prescribers and pharmacists who decide what gets used. A good field force in Ethiopia visits doctors and pharmacists, launches new products, carries their questions back to the manufacturer and passes on reports of suspected adverse reactions. When you assess a partner, count the medical representatives, check their qualifications, ask which regions they actually visit, and ask to see their reports. LifeCare Pharmaceutical Trading PLC runs more than 20 medical representatives in Addis Ababa and in different regions of Ethiopia.
What medical representatives in Ethiopia do for a manufacturer
Registration with the Ethiopian Food and Drug Authority (EFDA) lets a product be imported. It does not put the product in a prescriber's mind. Medical representatives close that gap, and for a foreign manufacturer who has never visited an Ethiopian hospital ward they do five jobs.
- Detailing to prescribers. A representative explains a product to doctors, nurses and clinical officers: the indication, the dose, how it differs from what the hospital already uses. The WHO criteria discussed below say representatives should give prescribers "complete and unbiased information" for every product they discuss.
- Working with pharmacists. Pharmacists and dispensers decide what to stock and which brand to recommend when a prescription allows a choice. A representative who is in the pharmacy every few weeks hears about stock-outs and substitutions before the importer's head office does.
- Launching products. A new registration usually means a launch plan: who is told, in which order, with what material, and when stock lands. Representatives carry that plan to the people it is meant for.
- Bringing feedback back. Pricing complaints, packaging problems, competitor activity and requests for a different pack size reach the manufacturer through the field force or not at all.
- Taking in adverse-event reports. A prescriber or pharmacist who sees a suspected reaction often mentions it to the representative first. The representative's job is to pass that on to whoever runs pharmacovigilance. How that chain should work is covered in our post on pharmacovigilance and the local agent.

The rules on promoting medicines in Ethiopia
Promotion of medicines in Ethiopia is regulated, and the regulator is EFDA. Its published list of powers under Regulation No. 531/2023 includes the duty to "regulate promotion of medicine and medical device with promotional materials and professionals" (EFDA, Powers and Duties page, checked 9 November 2026). That sentence tells you who is in charge. It does not tell you the detail.
For the detail we have a news report, not the directive text. We could not open the EFDA promotion guideline itself, so we are not going to describe its clauses. The Reporter covered an EFDA circular in February 2023 and reported that manufacturers, importers and wholesalers "should not employ and disseminate promotional materials without clearance from the Authority." The report adds that applicants must give the brand and generic names and details of the manufacturer and distributor, that companies must tell the Authority which licensed health workers are authorised to market their medicines, and that mass-media advertising of medicines stays prohibited except for items such as condoms and contraceptives (The Reporter, Samuel Bogale, 18 February 2023). Treat that as a dated press account and ask your partner for the current EFDA document.
Two practical points follow for a manufacturer. First, brochures, detail aids and presentations prepared abroad should not be handed out in Ethiopia until your local partner confirms they have been cleared. Second, a partner whose representatives promote without cleared material puts your registration at risk, not just its own licence.
Enforcement is a separate question. A 2019 study of promotional materials in Ethiopia said the criteria EFDA's predecessor used were adopted from WHO, noted that companies use pharmacists as medical representatives, and concluded that the WHO and national recommendations "are rarely met" in practice (Hailu et al., Drug, Healthcare and Patient Safety, 24 July 2019). A manufacturer should assume the rules exist and that compliance depends on the partner.
The WHO ethical criteria: the international baseline
The WHO Ethical Criteria for Medicinal Drug Promotion were adopted by the World Health Assembly in resolution WHA41.17 on 13 May 1988. They are a frame of reference, not a law, and many national regulators use them as a starting point. Three paragraphs concern medical representatives directly.
- Paragraph 17: representatives "should have an appropriate educational background," be adequately trained, and have enough medical and technical knowledge to present information "in an accurate and responsible manner." Employers carry the duty to train them, including on ethical conduct.
- Paragraph 18: representatives should give prescribers and dispensers complete and unbiased information, such as an approved scientific data sheet, for each product discussed.
- Paragraph 19: employers answer for what their representatives say and do. Representatives should not offer inducements to prescribers or dispensers, and "the main part of the remuneration" should not depend directly on sales volume, to avoid over-promotion.
These give a foreign manufacturer a checklist that needs no knowledge of Ethiopian law. Ask the partner about each of the three.
How to judge a partner's field force
A headline number such as "20 representatives" proves little by itself. Ask for the following, and expect a serious partner to answer within a day.
| Question | What a good answer looks like |
|---|---|
| Headcount | Employees on payroll, not freelancers or commission agents, split by city and region. |
| Qualifications | Pharmacy or other health-science degrees, plus a training record per representative (WHO paragraph 17). |
| Regional coverage | A named list of regions and towns visited, with visit frequency. Our post on distribution across Ethiopian regions explains why Addis Ababa alone is not the market. |
| Product load | How many principals each representative carries. A representative carrying forty products details none of them well. |
| Reporting | Call reports, a monthly summary to you, and a stated route for adverse-event reports. |
| Promotional material | Evidence that EFDA clearance is obtained before anything is handed out. |
| Pay structure | Fixed salary as the main component (WHO paragraph 19). |
Then check the partner itself. How to verify a medicine supplier in Ethiopia covers licences and registers, and appointing a local agent with EFDA covers the legal side of the relationship. A field force is worth little if the licence behind it is not in order.
Also decide which market you are selling into. Public tenders are decided mostly on price and documents, while private pharmacies and hospital chains respond to prescriber preference. Tender versus private market in Ethiopia sets out the difference, and it changes how much a field force is worth to you.
LifeCare's field force
LifeCare has more than 20 medical representatives, working in Addis Ababa and in different regions of Ethiopia. Ask us the questions in the table above: which towns each representative visits, how often, and what qualification each one holds. We will answer them for your product. LifeCare imports and distributes pharmaceuticals, medical equipment and medical supplies from its base in Addis Ababa and serves both the public tender market and the private market. See the pharmaceuticals range and the company page for the wider picture.
Frequently asked questions
How many medical representatives does a manufacturer need in Ethiopia?
There is no required number. The right figure depends on how many prescribers and pharmacies your product must reach and in which regions. Ask a partner how many representatives would handle your product and how many other principals they already carry.
Are medical representatives in Ethiopia required to be pharmacists?
We could not confirm a legal requirement from a primary source. A 2019 study reported that companies use pharmacists as representatives, and the WHO criteria ask for an appropriate educational background. Ask the partner for each representative's qualification.
Can a manufacturer advertise medicines to the public in Ethiopia?
According to a February 2023 report in The Reporter, mass-media advertising of medicines is prohibited except for items such as condoms and contraceptives. Confirm the current position with EFDA before planning any public campaign.
Who is responsible for what a representative says about my product?
Under WHO paragraph 19, the employer is responsible for the statements and activities of its representatives. In practice, you should also write approved product claims into your agreement with the partner.
Do representatives handle adverse-event reports?
They often receive the first report from a prescriber or pharmacist and should pass it on. Who then reports to EFDA depends on how pharmacovigilance is arranged between you and your partner.
If you are a manufacturer weighing Ethiopian partners, our team will tell you how we would cover your product. See our partners page or contact us.